Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191198
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2023-12-20
Brief Title:
Communication Bridge 3 Study
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
Communication Bridge Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CB3
Brief Summary:
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia PPA The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA
Detailed Description:
Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for approximately 17 months Each participant will receive a laptop equipped with the necessary applications and features for the study Participants will receive up to 10 evaluations and 20 speech therapy sessions with a licensed speech therapist as well as access to Communication Bridge a personalized web application to practice home exercises that reinforce treatment strategies There are no costs to participate in this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 7R01AG055425-07 | NIH | None | httpsreporternihgovquickSearch7R01AG055425-07 |